APA (7th ed.) Citation

Bochtler, T., Reiling, A., Endris, V., Hielscher, T., Volckmar, A., Neumann, O., . . . Krämer, A. (2020). Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International journal of cancer, 146(11), . https://doi.org/https://doi.org/10.1002/ijc.32882

Chicago Style (17th ed.) Citation

Bochtler, Tilmann, et al. "Integrated Clinicomolecular Characterization Identifies RAS Activation and CDKN2A Deletion as Independent Adverse Prognostic Factors in Cancer of Unknown Primary." International Journal of Cancer 146, no. 11 (2020). https://doi.org/https://doi.org/10.1002/ijc.32882.

MLA (9th ed.) Citation

Bochtler, Tilmann, et al. "Integrated Clinicomolecular Characterization Identifies RAS Activation and CDKN2A Deletion as Independent Adverse Prognostic Factors in Cancer of Unknown Primary." International Journal of Cancer, vol. 146, no. 11, 2020, https://doi.org/https://doi.org/10.1002/ijc.32882.